334 related articles for article (PubMed ID: 20478998)
1. Pleiotropic role for MYCN in medulloblastoma.
Swartling FJ; Grimmer MR; Hackett CS; Northcott PA; Fan QW; Goldenberg DD; Lau J; Masic S; Nguyen K; Yakovenko S; Zhe XN; Gilmer HC; Collins R; Nagaoka M; Phillips JJ; Jenkins RB; Tihan T; Vandenberg SR; James CD; Tanaka K; Taylor MD; Weiss WA; Chesler L
Genes Dev; 2010 May; 24(10):1059-72. PubMed ID: 20478998
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
[TBL] [Abstract][Full Text] [Related]
3. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.
Ryan SL; Schwalbe EC; Cole M; Lu Y; Lusher ME; Megahed H; O'Toole K; Nicholson SL; Bognar L; Garami M; Hauser P; Korshunov A; Pfister SM; Williamson D; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2012 Apr; 123(4):501-13. PubMed ID: 22139329
[TBL] [Abstract][Full Text] [Related]
4. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract][Full Text] [Related]
5. Childhood tumors of the nervous system as disorders of normal development.
Grimmer MR; Weiss WA
Curr Opin Pediatr; 2006 Dec; 18(6):634-8. PubMed ID: 17099362
[TBL] [Abstract][Full Text] [Related]
6. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.
Swartling FJ; Savov V; Persson AI; Chen J; Hackett CS; Northcott PA; Grimmer MR; Lau J; Chesler L; Perry A; Phillips JJ; Taylor MD; Weiss WA
Cancer Cell; 2012 May; 21(5):601-613. PubMed ID: 22624711
[TBL] [Abstract][Full Text] [Related]
7. Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.
Ahmad Z; Jasnos L; Gil V; Howell L; Hallsworth A; Petrie K; Sawado T; Chesler L
PLoS One; 2015; 10(3):e0119834. PubMed ID: 25785590
[TBL] [Abstract][Full Text] [Related]
8. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
[TBL] [Abstract][Full Text] [Related]
9. An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling.
Wijaya J; Vo BT; Liu J; Xu B; Wu G; Wang Y; Peng J; Zhang J; Janke LJ; Orr BA; Yu J; Roussel MF; Schuetz JD
Cancer Res; 2020 Apr; 80(7):1524-1537. PubMed ID: 31948942
[TBL] [Abstract][Full Text] [Related]
10. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development.
Zhao H; Ayrault O; Zindy F; Kim JH; Roussel MF
Genes Dev; 2008 Mar; 22(6):722-7. PubMed ID: 18347090
[TBL] [Abstract][Full Text] [Related]
11. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression.
Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V
Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842
[TBL] [Abstract][Full Text] [Related]
12. Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
Park AK; Lee SJ; Phi JH; Wang KC; Kim DG; Cho BK; Haberler C; Fattet S; Dufour C; Puget S; Sainte-Rose C; Bourdeaut F; Grill J; Delattre O; Kim SK; Park WY
Neuro Oncol; 2012 Feb; 14(2):203-14. PubMed ID: 22090452
[TBL] [Abstract][Full Text] [Related]
13. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice.
Rao G; Pedone CA; Del Valle L; Reiss K; Holland EC; Fults DW
Oncogene; 2004 Aug; 23(36):6156-62. PubMed ID: 15195141
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.
Chen Z; Lin Y; Barbieri E; Burlingame S; Hicks J; Ludwig A; Shohet JM
Neoplasia; 2009 Aug; 11(8):753-62. PubMed ID: 19649205
[TBL] [Abstract][Full Text] [Related]
15. MDM2 as a critical effector of the MYCN oncogene in tumorigenesis.
Slack A; Shohet JM
Cell Cycle; 2005 Jul; 4(7):857-60. PubMed ID: 15917661
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
17. An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma.
De Smaele E; Fragomeli C; Ferretti E; Pelloni M; Po A; Canettieri G; Coni S; Di Marcotullio L; Greco A; Moretti M; Di Rocco C; Pazzaglia S; Maroder M; Screpanti I; Giannini G; Gulino A
Neoplasia; 2008 Jan; 10(1):89-98. PubMed ID: 18231642
[TBL] [Abstract][Full Text] [Related]
18. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
[TBL] [Abstract][Full Text] [Related]
19. Lipidome signatures of metastasis in a transgenic mouse model of sonic hedgehog medulloblastoma.
Huang D; Liu J; Eldridge RC; Gaul DA; Paine MRL; Uppal K; MacDonald TJ; Fernández FM
Anal Bioanal Chem; 2020 Oct; 412(25):7017-7027. PubMed ID: 32794007
[TBL] [Abstract][Full Text] [Related]
20. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]